Studies evaluating titration of antihypertensive medication using self-monitoring give contradictory findings and the precise place of telemonitoring over self-monitoring alone is unclear. The TASMINH4 trial aimed to assess the efficacy of self-monitored blood pressure, with or without telemonitoring, for antihypertensive titration in primary care, compared with usual care.
This study was a parallel randomised controlled t...
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Programme Grant for Applied Health Research (RP-PG-1209-10051); Professorship to RJM (NIHR-RP-R2-12-015)
- Elsevier: Lancet Publisher's website
- Lancet Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Copyright holder:
- RJ McManus et al.
- Copyright date:
- © 2018 The Author(s). Published by Elsevier Ltd. Open Access funded by Department of Health UK, available under a Creative Commons license.
Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial
If you are the owner of this record, you can report an update to it here: Report update to this record